abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
17421: Cea, Peritoneal Fluid Print View
CEA, Peritoneal Fluid IA    ng/mL 

PRIMARY
1 Fluid Peritoneal 3 (2) mL   Frozen - 28 Day(s)/Refrigerated - 28 Day(s)/Room Temperature - 7 Day(s)  
ALTERNATE

CEA is a tumor marker that is useful to monitor patients with persistent, or for recurrent or metastatic colonic carcinoma. As many as 30% of patients with breast, lung, hepatocellular, and pancreatic carcinoma also have elevated concentrations of CEA. Individuals who smoke may have a slightly higher baseline than non-smokers.
Setup Schedule
Wednesday

Reported (Analytical Time)
Next day

CPT Code
82378

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Transport Temperature: Frozen Assay Category: FDA Approved/Modified Reject Criteria: Gross hemolysis; pancreatic fluid






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database